Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study.
Suzanne R ThibodeauxDean CobleVictoria DayMagali J FontaineMaria GabelliNicola GardinerTamara GeachJoseph SchwartzLjiljana V VasovicRachael WyreJohn Girdlestonenull nullPublished in: Transfusion (2023)
While there were no apparent changes to most parameters studied, there was an indication of slower neutrophil engraftment that will need to be examined in larger, longer term studies.